SHPHShuttle Pharmaceuticals Holdings Inc. Common Stock

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · shuttlepharma.com

3.760USD0.00%Mkt Cap: 2.20M $P/E: 37.603d ago

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular dis…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap2.20M $

Enterprise Value1.29M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-11.72M $

Revenue/Share—

Last Price3.760 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees2

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)37.60

P/E (Forward)—

PEG—

EV/EBITDA-0.12

EV/Revenue—

P/S—

P/B0.62

EPS (TTM)0.10

EPS (Forward)—

52W Range

2.5762% of range55.90

52W High55.90 USD

52W Low2.576 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-519.94%

ROA-111.89%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-9.48M $

CapEx (TTM)3.06M $

FCF Margin—

FCF Yield33.68%

Net Debt-875.93K $

Net Debt/EBITDA0.08

Balance Sheet

Debt/Equity0.10

Current Ratio0.30

Quick Ratio0.13

Book Value/Sh6.028 USD

Cash/Share1.863 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateJun 11, 2026

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.585.13K

Float582.38K

Insiders3.90%

Institutions8.94%

Short Interest

Short Ratio0.0d

Short % Float9.76%

Short % Out.9.64%

Shares Short56.38K

Short (prev mo.)137.27K

Technical

SMA 503.656 (+2.8%)

SMA 20010.73 (-65.0%)

Beta1.22

S&P 52W Chg18.16%

Avg Vol (30d)2.06M

Avg Vol (10d)39.97K

Technical Indicators

RSI (14)48.5

MACD0.1035

MACD Signal0.0892

MACD Hist.+0.0142

BB Upper4.982 USD

BB Middle3.725 USD

BB Lower2.468 USD

BB Width67.47%

ATR (14)0.4950 USD

Vol Ratio (20d)0.03x